Re: Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy: W. C. Duivenvoorden, S. Daneshmand, D. Canter, Y. Lotan, P. C. Black, H. Abdi, B. W. van Rhijn, E. E. Fransen van de Putte, P. Zareba, I. Koskinen, W. Kassouf, S. L. Traboulsi, J. E. Kukreja, P. J. Boström, B. Shayegan and J. H. Pinthus J Urol 2016;196:1627-1633.
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington. Electronic address: jdramos@fhcrc.org.
Jorge D
JD
Ramos
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Evan Y
EY
Yu
D002295:Carcinoma, Transitional Cell; D006801:Humans; D015994:Incidence; D020360:Neoadjuvant Therapy; D001749:Urinary Bladder Neoplasms